Pazopanib
- Level
- Commodity
- Parent
- 51112000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112006This classification denotes a tyrosine kinase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7RN5DR86CK. European Medicines Agency schedules Pazopanib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29175. Pazopanib generally arises in the molecular formula C21H23N7O2S. The term PAZOPANIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56.) As of Q4 2014, PAZOPANIB remains the US FDA Preferred Term for this commodity. Pazopanib bears US NLM identifiers UMLS ID C1831796 and NCI Concept Code C74547. SMILES: CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.
Same parent
Under 51112000 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.